Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-α transgenic mice

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 2, 2006, Pages 274-278

  Puatanachokchai, Rawiwan ^a   Kakuni, Masakazu ^a   Wanibuchi, Hideki ^a   Kinoshita, Anna ^a   Kang, Jin Seok ^a   Salim, Elsayed I ^a   Morimura, Keiichirou ^a   Tamano, Seiko ^b   Merlino, Glenn T ^c   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Daiyukai Research Institute for Medical Science   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer risk assessment; Hepatocarcinogenesis; Phenobarbital; TGF ; Transgenic mouse model

Indexed keywords

ANTICONVULSIVE AGENT; CARCINOGEN; DIETHYLNITROSAMINE; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ARTICLE; CARCINOGEN TESTING; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GENETICS; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTICONVULSANTS; CARCINOGENICITY TESTS; CARCINOGENS; DIETHYLNITROSAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33748466762     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burdon RH (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad Biol Med, 18, 775-94.
2. Butterworth BE, Conolly RB, Morgan KT (1995). A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessment. Cancer Lett, 93, 129-46.
3. Diwan BA, Henneman JR, Rice JM, et al (1996). Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)benzene in rats at doses that cause maximal induction of CYP2B. Carcinogenesis, 17, 37-43.
4. Factor VM, Kiss A, Woitach JT, et al (1998). Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem, 273, 15846-53.
5. Feldman D, Swarm RL, Becker J (1981). Ultrastructural study of rat liver and liver neoplasms after long-term treatment with phenobarbital. Cancer Res, 41, 2151-62.
6. Fukushima S, Kinoshita A, Puatanachokchai R, et al (2005). Hormesis and dose response-mediated mechanisms in carcinogenesis evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Carcinogenesis, 26, 1835-45.
7. Goldsworthy T, Campell HA, Pitot HC (1984). The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis, 5, 67-71.
8. Jhappan C, Stahle C, Harkins RN, et al (1990). TGF-a overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61, 1137-46.
9. Kasai H, Crain PF, Kuchino Y, et al (1986). Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis, 7, 1849-51.
10. Kaufmann WK, Ririe DG., Kaufman DG. (1988). Phenobarbital dependent proliferation of putative initiated rat hepatocytes. Carcinogenesis, 9, 779-82.
11. Kinoshita A, Wanibuchi H, Morimura K, et al (2003). Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis, 24, 1389-99.
12. Kitagawa T, Hino O, Nomura K, et al (1984). Dose-response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis, 5, 1653-6.
13. Kitano M, Ichihara T, Matsuda T, et al (1988). Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis, 19, 1475-80.
14. Kolaja KL, Stevenson DE, Walborg EF, et al (1996). Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis, 17, 947-54.
15. Kushida M, Sukata T, Uwagawa S, et al (2005). Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: Possible mechanisms. Toxicol App Pharm, 208, 285-94.
16. Nakae D, Mizumoto Y, Kobayashi E, et al (1995). Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amount of rat liver tissue. Cancer Lett, 97, 233-9.
17. Nakamura H, Nakamura K, Yodoi J (1997). Redox regulation of cellular activation. Annu Rev Immunol, 15, 351-69.
18. Omura T, Sato R (1964). The carbon monoxide-binding pigment of liver microsomes. Solubilization, purification, and properties. J Biol Chem, 239, 2379-85.
19. Oslen JH, Schulgen G., Boice JD, et al (1995). Antiepileptictreatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res, 55, 294-7.
20. Puatanachokchai R, Morimura K, Wanibuchi H, et al (2006). Alphabenzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes. Cancer Lett, [Epub ahead of print]
21. Schulte-Herman R, Timmermann-Trosiener I, Schuppler J (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res, 43, 839-44.
22. Suzuki YJ, Forman HJ, Sevanian A (1997). Oxidants as stimulators of signal transduction. Free Rad Biol Med, 22, 269-85.
23. Takagi H, Sharp R, Takayama H, et al (1993). Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Cancer Res, 53, 4329-36.
24. Tamano S, Merlino G.T, Ward JM (1994). Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by Nnitrosodiethylamine and promoted by phenobarbital. Carcinogenesis, 15, 1791-8.
25. Valko M, Ikzakovic M, Mazur M, et al (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem, 226, 37-56.
26. Ward JM, Henneman JR (1990). Naturally-occurring agedependent glutathione S-transferase pi immunoreactive hepatocytes in aging female F344 rat liver as potential promotable targets for non-genotoxic carcinogens. Cancer Lett, 52, 187-95.
27. Webber EM, Wu JC, Wang L, et al (1994). Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol, 145, 398-408.